Updated: Amgen's Horizon buyout powers growth, with MariTide plans intact
Amgen’s Horizon deal is starting to pay off, as the biotech giant reported a 20% increase in quarterly revenue compared with the year prior. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
